Skip to main content
Regena Peptides laboratory research video
REGENA PEPTIDES

Research Library

A reference library for peptide and longevity research

Every page here follows the same structure: what the compound or process is, how it works, what laboratory, animal and human research has actually shown, what remains unknown, and where to read the primary sources. Nothing here is medical advice or a protocol.

Categories

Recently reviewed

What Is BPC-157? Mechanisms, Evidence and Research Gaps

BPC-157 is a synthetic 15–amino-acid peptide derived from a sequence identified in human gastric juice. It is investigated for tissue repair, angiogenesis and gut barrier function. Almost all published evidence comes from rodent models; controlled human data is very limited, and long-term safety has not been characterised.

What Is TB-500? Thymosin Beta-4 Research Explained

TB-500 is a synthetic fragment of thymosin beta-4, a naturally occurring actin-sequestering protein involved in cell migration and wound repair. Research has focused on wound healing, corneal injury and cardiac repair. Thymosin beta-4 itself reached early human trials; the TB-500 fragment sold for laboratory use has not.

How GHK-Cu Works: Copper Peptide Research Explained

GHK-Cu is a naturally occurring copper-binding tripeptide (glycyl-L-histidyl-L-lysine) found in human plasma, saliva and urine. Plasma levels fall with age, which prompted research into skin remodelling, wound repair and gene expression. It has the strongest human evidence base of the classic repair peptides, largely from dermatology.

KPV Peptide Research: Anti-Inflammatory Tripeptide Explained

KPV is the C-terminal tripeptide fragment (lysine–proline–valine) of alpha-melanocyte-stimulating hormone. It retains much of the parent hormone's anti-inflammatory signalling without its pigmentary effects. Research is concentrated in experimental colitis and dermatitis models; human trials are minimal.

MOTS-c Research: Mitochondrial-Derived Peptide Explained

MOTS-c is a 16–amino-acid peptide encoded within the mitochondrial 12S rRNA gene — one of the first recognised mitochondrial-derived peptides. Research links it to AMPK activation, metabolic flexibility and exercise adaptation. Nearly all functional data comes from cell and rodent work; human research is observational.

SS-31 (Elamipretide): Cardiolipin-Targeted Peptide Research

SS-31, developed clinically as elamipretide, is a cell-permeable tetrapeptide that concentrates in the inner mitochondrial membrane and binds cardiolipin. It is one of the few research peptides with a substantial registered clinical trial programme, most notably in primary mitochondrial myopathy and Barth syndrome, with mixed results.

Epitalon Research: Telomerase Claims Versus the Evidence

Epitalon is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) derived from epithalamin, a pineal gland extract studied in the former Soviet Union. It is widely promoted for telomerase activation and lifespan extension. The underlying studies are old, mostly from one institute, and largely fail modern methodological standards — this is the weakest evidence base of the compounds covered here.

Thymosin Alpha-1 Research: Immune Signalling Evidence

Thymosin alpha-1 is a 28–amino-acid peptide derived from prothymosin alpha, produced by the thymus and involved in T-cell maturation. Of the peptides covered in this hub it has the most extensive human trial record — it is approved in around thirty countries for hepatitis B and as a vaccine adjuvant — but it is not approved in the US, EU or UK.

All guides

What Is BPC-157? Mechanisms, Evidence and Research GapsWhat Is TB-500? Thymosin Beta-4 Research ExplainedHow GHK-Cu Works: Copper Peptide Research ExplainedKPV Peptide Research: Anti-Inflammatory Tripeptide ExplainedMOTS-c Research: Mitochondrial-Derived Peptide ExplainedSS-31 (Elamipretide): Cardiolipin-Targeted Peptide ResearchEpitalon Research: Telomerase Claims Versus the EvidenceThymosin Alpha-1 Research: Immune Signalling EvidenceRetatrutide Research: Triple Receptor Agonism ExplainedTirzepatide Research: Dual GIP/GLP-1 Agonism EvidenceSemaglutide Research: GLP-1 Evidence and OutcomesCagrilintide Research: Amylin Analogue EvidenceHow Incretin Peptides Work: Mechanisms of Action ExplainedIncretin Side Effects: What the Trial Data ReportsCombination Research: Why Multi-Pathway Agents Are StudiedCellular Health and Ageing: The Hallmarks FrameworkMitochondrial Function and Ageing: What the Research ShowsChronic Inflammation and Inflammaging: Research OverviewOxidative Stress: Beyond the Free Radical TheoryAgeing Biomarkers: Epigenetic Clocks and Functional MeasuresTestosterone Research: Physiology, Measurement and EvidenceGrowth Hormone Research: Physiology and the Anti-Ageing ClaimsIGF-1 Research: The Growth–Longevity Trade-OffMetabolic Health: Insulin Sensitivity and How It Is MeasuredRetatrutide vs Tirzepatide: What the Trial Data ShowsTirzepatide vs Semaglutide: The SURMOUNT-5 Head-to-HeadCagrilintide vs Semaglutide: Amylin and Incretin ComparedBPC-157 vs TB-500: Two Preclinical Repair Peptides ComparedMOTS-c vs SS-31: Two Approaches to Mitochondrial Research
© 2026 Regena Peptides · Marbella · Educational research reference · For in-vitro research use only

Trusted reference supplier · Verified across review platforms

We accept · Multiple secure payment methods

  • Bank Transfer
  • Card via Revolut